Allstate Corp Horizon Therapeutics Public LTD CO Transaction History

Allstate Corp

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$62.39 - $113.8 $391,933 - $714,891	6,282 New	6,282 $714,000
Q2 2022 Aug 15, 2022	SELL	$79.4 - $116.36 $1.03 Million - $1.52 Million	-13,020 Reduced 72.66%	4,898 $391,000
Q1 2022 May 16, 2022	BUY	$86.42 - $109.81 $1.23 Million - $1.56 Million	14,221 Added 384.66%	17,918 $1.89 Million
Q4 2021 Feb 15, 2022	SELL	$98.56 - $119.91 $19,120 - $23,262	-194 Reduced 4.99%	3,697 $398,000
Q3 2021 Nov 15, 2021	SELL	$91.91 - $110.37 $59,741 - $71,740	-650 Reduced 14.31%	3,891 $426,000
Q2 2021 Aug 16, 2021	SELL	$86.24 - $95.92 $40,446 - $44,986	-469 Reduced 9.36%	4,541 $425,000
Q1 2021 May 14, 2021	BUY	$71.83 - $95.48 $36,633 - $48,694	510 Added 11.33%	5,010 $461,000
Q4 2020 Feb 12, 2021	BUY	$67.0 - $84.39 $301,500 - $379,755	4,500 New	4,500 $329,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Allstate Corp, based on Form 13F filings with the SEC.

Stay updated on Allstate Corp with notifications on news.